Table of Contents
Global Pancreatic Endocrine Tumor Drug Sales Market Report 2021
1 Pancreatic Endocrine Tumor Drug Market Overview
1.1 Product Overview and Scope of Pancreatic Endocrine Tumor Drug
1.2 Classification of Pancreatic Endocrine Tumor Drug by Product Category
1.2.1 Global Pancreatic Endocrine Tumor Drug Market Size (Sales) Comparison by Type ( 2016 - 2027)
1.2.2 Global Pancreatic Endocrine Tumor Drug Market Size (Sales) Market Share by Type (Product Category) in 2020
1.2.3 Buparlisib Hydrochloride
1.2.4 Dovitinib Lactate
1.2.5 Fosbretabulin Tromethamine
1.2.6 Lanreotide Acetate
1.2.7 MPHE - 001B
1.2.8 Others
1.3 Global Pancreatic Endocrine Tumor Drug Market by Application/End Users
1.3.1 Global Pancreatic Endocrine Tumor Drug Sales (Volume) and Market Share Comparison by Application ( 2016 - 2027)
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.4 Global Pancreatic Endocrine Tumor Drug Market by Region
1.4.1 Global Pancreatic Endocrine Tumor Drug Market Size (Value) Comparison by Region ( 2016 - 2027)
1.4.2 United States Pancreatic Endocrine Tumor Drug Status and Prospect ( 2016 - 2027)
1.4.3 Europe Pancreatic Endocrine Tumor Drug Status and Prospect ( 2016 - 2027)
1.4.4 China Pancreatic Endocrine Tumor Drug Status and Prospect ( 2016 - 2027)
1.4.5 Japan Pancreatic Endocrine Tumor Drug Status and Prospect ( 2016 - 2027)
1.4.6 Southeast Asia Pancreatic Endocrine Tumor Drug Status and Prospect ( 2016 - 2027)
1.4.7 India Pancreatic Endocrine Tumor Drug Status and Prospect ( 2016 - 2027)
1.5 Global Market Size (Value and Volume) of Pancreatic Endocrine Tumor Drug ( 2016 - 2027)
1.5.1 Global Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2027)
1.5.2 Global Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2027)
2 Global Pancreatic Endocrine Tumor Drug Competition by Players/Suppliers, Type and Application
2.1 Global Pancreatic Endocrine Tumor Drug Market Competition by Players/Suppliers
2.1.1 Global Pancreatic Endocrine Tumor Drug Sales and Market Share of Key Players/Suppliers ( 2016 - 2021)
2.1.2 Global Pancreatic Endocrine Tumor Drug Revenue and Share by Players/Suppliers ( 2016 - 2021)
2.2 Global Pancreatic Endocrine Tumor Drug (Volume and Value) by Type
2.2.1 Global Pancreatic Endocrine Tumor Drug Sales and Market Share by Type ( 2016 - 2021)
2.2.2 Global Pancreatic Endocrine Tumor Drug Revenue and Market Share by Type ( 2016 - 2021)
2.3 Global Pancreatic Endocrine Tumor Drug (Volume and Value) by Region
2.3.1 Global Pancreatic Endocrine Tumor Drug Sales and Market Share by Region ( 2016 - 2021)
2.3.2 Global Pancreatic Endocrine Tumor Drug Revenue and Market Share by Region ( 2016 - 2021)
2.4 Global Pancreatic Endocrine Tumor Drug (Volume) by Application
3 United States Pancreatic Endocrine Tumor Drug (Volume, Value and Sales Price)
3.1 United States Pancreatic Endocrine Tumor Drug Sales and Value ( 2016 - 2021)
3.1.1 United States Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2021)
3.1.2 United States Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2021)
3.1.3 United States Pancreatic Endocrine Tumor Drug Sales Price Trend ( 2016 - 2021)
3.2 United States Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Players ( 2016 - 2021)
3.3 United States Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Type ( 2016 - 2021)
3.4 United States Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Application ( 2016 - 2021)
4 Europe Pancreatic Endocrine Tumor Drug (Volume, Value and Sales Price)
4.1 Europe Pancreatic Endocrine Tumor Drug Sales and Value ( 2016 - 2021)
4.1.1 Europe Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2021)
4.1.2 Europe Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2021)
4.1.3 Europe Pancreatic Endocrine Tumor Drug Sales Price Trend ( 2016 - 2021)
4.2 Europe Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Players ( 2016 - 2021)
4.3 Europe Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Type ( 2016 - 2021)
4.4 Europe Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Application ( 2016 - 2021)
5 China Pancreatic Endocrine Tumor Drug (Volume, Value and Sales Price)
5.1 China Pancreatic Endocrine Tumor Drug Sales and Value ( 2016 - 2021)
5.1.1 China Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2021)
5.1.2 China Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2021)
5.1.3 China Pancreatic Endocrine Tumor Drug Sales Price Trend ( 2016 - 2021)
5.2 China Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Players ( 2016 - 2021)
5.3 China Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Type ( 2016 - 2021)
5.4 China Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Application ( 2016 - 2021)
6 Japan Pancreatic Endocrine Tumor Drug (Volume, Value and Sales Price)
6.1 Japan Pancreatic Endocrine Tumor Drug Sales and Value ( 2016 - 2021)
6.1.1 Japan Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2021)
6.1.2 Japan Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2021)
6.1.3 Japan Pancreatic Endocrine Tumor Drug Sales Price Trend ( 2016 - 2021)
6.2 Japan Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Players ( 2016 - 2021)
6.3 Japan Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Type ( 2016 - 2021)
6.4 Japan Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Application ( 2016 - 2021)
7 Southeast Asia Pancreatic Endocrine Tumor Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Pancreatic Endocrine Tumor Drug Sales and Value ( 2016 - 2021)
7.1.1 Southeast Asia Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2021)
7.1.2 Southeast Asia Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2021)
7.1.3 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Price Trend ( 2016 - 2021)
7.2 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Players ( 2016 - 2021)
7.3 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Type ( 2016 - 2021)
7.4 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Application ( 2016 - 2021)
8 India Pancreatic Endocrine Tumor Drug (Volume, Value and Sales Price)
8.1 India Pancreatic Endocrine Tumor Drug Sales and Value ( 2016 - 2021)
8.1.1 India Pancreatic Endocrine Tumor Drug Sales and Growth Rate ( 2016 - 2021)
8.1.2 India Pancreatic Endocrine Tumor Drug Revenue and Growth Rate ( 2016 - 2021)
8.1.3 India Pancreatic Endocrine Tumor Drug Sales Price Trend ( 2016 - 2021)
8.2 India Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Players ( 2016 - 2021)
8.3 India Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Type ( 2016 - 2021)
8.4 India Pancreatic Endocrine Tumor Drug Sales Volume and Market Share by Application ( 2016 - 2021)
9 Global Pancreatic Endocrine Tumor Drug Players/Suppliers Profiles and Sales Data
9.1 Ipsen S.A.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Pancreatic Endocrine Tumor Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.1.4 Main Business/Business Overview
9.2 Jiangsu Hengrui Medicine Co., Ltd.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Pancreatic Endocrine Tumor Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.2.4 Main Business/Business Overview
9.3 MediaPharma s.r.l.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Pancreatic Endocrine Tumor Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.3.4 Main Business/Business Overview
9.4 Novartis AG
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Pancreatic Endocrine Tumor Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.4.4 Main Business/Business Overview
9.5 OXiGENE, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Pancreatic Endocrine Tumor Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.5.4 Main Business/Business Overview
...
10 Pancreatic Endocrine Tumor Drug Maufacturing Cost Analysis
10.1 Pancreatic Endocrine Tumor Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug
10.3 Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Pancreatic Endocrine Tumor Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Pancreatic Endocrine Tumor Drug Major Manufacturers in 2020
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Pancreatic Endocrine Tumor Drug Market Forecast ( 2021 - 2027)
14.1 Global Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Price Forecast ( 2021 - 2027)
14.1.1 Global Pancreatic Endocrine Tumor Drug Sales Volume and Growth Rate Forecast ( 2021 - 2027)
14.1.2 Global Pancreatic Endocrine Tumor Drug Revenue and Growth Rate Forecast ( 2021 - 2027)
14.1.3 Global Pancreatic Endocrine Tumor Drug Price and Trend Forecast ( 2021 - 2027)
14.2 Global Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast by Region ( 2021 - 2027)
14.2.1 Global Pancreatic Endocrine Tumor Drug Sales Volume and Growth Rate Forecast by Regions ( 2021 - 2027)
14.2.2 Global Pancreatic Endocrine Tumor Drug Revenue and Growth Rate Forecast by Regions ( 2021 - 2027)
14.2.3 United States Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.4 Europe Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.5 China Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.6 Japan Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.7 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.8 India Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.3 Global Pancreatic Endocrine Tumor Drug Sales Volume, Revenue and Price Forecast by Type ( 2021 - 2027)
14.3.1 Global Pancreatic Endocrine Tumor Drug Sales Forecast by Type ( 2021 - 2027)
14.3.2 Global Pancreatic Endocrine Tumor Drug Revenue Forecast by Type ( 2021 - 2027)
14.3.3 Global Pancreatic Endocrine Tumor Drug Price Forecast by Type ( 2021 - 2027)
14.4 Global Pancreatic Endocrine Tumor Drug Sales Volume Forecast by Application ( 2021 - 2027)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Pancreatic Endocrine Tumor Drug
Figure Global Pancreatic Endocrine Tumor Drug Sales Volume Comparison (K Pcs) by Type ( 2016 - 2027)
Figure Global Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Type (Product Category) in 2020
Figure Buparlisib Hydrochloride Product Picture
Figure Dovitinib Lactate Product Picture
Figure Fosbretabulin Tromethamine Product Picture
Figure Lanreotide Acetate Product Picture
Figure MPHE - 001B Product Picture
Figure Others Product Picture
Figure Global Pancreatic Endocrine Tumor Drug Sales Comparison (K Pcs) by Application ( 2016 - 2027)
Figure Global Sales Market Share of Pancreatic Endocrine Tumor Drug by Application in 2020
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Global Pancreatic Endocrine Tumor Drug Market Size (Million USD) by Regions ( 2016 - 2027)
Figure United States Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure China Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Japan Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Southeast Asia Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure India Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) and Growth Rate ( 2016 - 2027)
Figure Global Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Market Major Players Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) of Key Players/Suppliers ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Sales Share by Players/Suppliers ( 2016 - 2021)
Figure 2020 Pancreatic Endocrine Tumor Drug Sales Share by Players/Suppliers
Figure 2020 Pancreatic Endocrine Tumor Drug Sales Share by Players/Suppliers
Figure Global Pancreatic Endocrine Tumor Drug Revenue (Million USD) by Players/Suppliers ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Revenue (Million USD) by Players/Suppliers ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Revenue Share by Players/Suppliers ( 2016 - 2021)
Table 2020 Global Pancreatic Endocrine Tumor Drug Revenue Share by Players
Table 2020 Global Pancreatic Endocrine Tumor Drug Revenue Share by Players
Table Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Market Share by Type ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Sales Share (K Pcs) by Type ( 2016 - 2021)
Figure Sales Market Share of Pancreatic Endocrine Tumor Drug by Type ( 2016 - 2021)
Figure Global Pancreatic Endocrine Tumor Drug Sales Growth Rate by Type ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Market Share by Type ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Revenue Share by Type ( 2016 - 2021)
Figure Revenue Market Share of Pancreatic Endocrine Tumor Drug by Type ( 2016 - 2021)
Figure Global Pancreatic Endocrine Tumor Drug Revenue Growth Rate by Type ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) and Market Share by Region ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Sales Share by Region ( 2016 - 2021)
Figure Sales Market Share of Pancreatic Endocrine Tumor Drug by Region ( 2016 - 2021)
Figure Global Pancreatic Endocrine Tumor Drug Sales Growth Rate by Region in 2020
Table Global Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Market Share by Region ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Revenue Share (%) by Region ( 2016 - 2021)
Figure Revenue Market Share of Pancreatic Endocrine Tumor Drug by Region ( 2016 - 2021)
Figure Global Pancreatic Endocrine Tumor Drug Revenue Growth Rate by Region in 2020
Table Global Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Market Share by Region ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Revenue Share (%) by Region ( 2016 - 2021)
Figure Revenue Market Share of Pancreatic Endocrine Tumor Drug by Region ( 2016 - 2021)
Figure Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Region in 2020
Table Global Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) and Market Share by Application ( 2016 - 2021)
Table Global Pancreatic Endocrine Tumor Drug Sales Share (%) by Application ( 2016 - 2021)
Figure Sales Market Share of Pancreatic Endocrine Tumor Drug by Application ( 2016 - 2021)
Figure Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application ( 2016 - 2021)
Figure United States Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate ( 2016 - 2021)
Figure United States Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2021)
Figure United States Pancreatic Endocrine Tumor Drug Sales Price (USD/Pcs) Trend ( 2016 - 2021)
Table United States Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Players ( 2016 - 2021)
Table United States Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Players ( 2016 - 2021)
Figure United States Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Players in 2020
Table United States Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Type ( 2016 - 2021)
Table United States Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Type ( 2016 - 2021)
Figure United States Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Type in 2020
Table United States Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Application ( 2016 - 2021)
Table United States Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Application ( 2016 - 2021)
Figure United States Pancreatic Endocrine Tumor Drug Sales Volume Market Share by Application in 2020
Figure Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) and Growth Rate ( 2016 - 2021)
Figure Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) and Growth Rate ( 2016 - 2021)
Figure Europe Pancreatic Endocrine Tumor Drug Sales Price (USD/Pcs) Trend ( 2016 - 2021)
Table Europe Pancreatic Endocrine Tumor Drug Sales Volume (K Pcs) by Players ( 2016 - 2021)
Table Europe Pancreatic Endocrine Tumor Drug Sales Volume Market Share by
